# Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma

> **NCT07661771** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 568 (estimated)

## Conditions studied

- Non-metastatic Nasopharyngeal Carcinoma

## Interventions

- **PROCEDURE:** Comprehensive Therapy Based on Tumor Stage
- **RADIATION:** IMRT with Primary Clinical Target Volume Based on Margin Expansion
- **RADIATION:** IMRT with Consensus Primary Clinical Target Volume

## Key facts

- **NCT ID:** NCT07661771
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-24
- **Primary completion:** 2029-07-30
- **Final completion:** 2034-07-30
- **Target enrollment:** 568 (ESTIMATED)
- **Last updated:** 2026-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07661771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07661771, "Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07661771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*